These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2664751)

  • 1. Renal function studies with cadralazine in conscious dogs: a comparison with hydralazine.
    Ferni G; Bonardi G; Lombroso M; Semeraro C; Dorigotti L
    Pharmacol Res; 1989; 21(2):211-22. PubMed ID: 2664751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive activity of cadralazine in experimental hypertensive rats.
    Takeyama K; Ikeno A; Minato H; Fukuya F; Nishimura S; Hosoki K; Kadokawa T
    Arch Int Pharmacodyn Ther; 1988; 291():163-74. PubMed ID: 3365060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological studies on cadralazine: a new antihypertensive vasodilator drug.
    Semeraro C; Dorigotti L; Banfi S; Carpi C
    J Cardiovasc Pharmacol; 1981; 3(3):455-67. PubMed ID: 6168827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
    Sim MF; Yates DB; Parkinson R; Cooling MJ
    Br J Pharmacol; 1988 Jun; 94(2):371-80. PubMed ID: 3293682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of cadralazine in hexamethonium treated and non-treated anesthetized dogs.
    Higashio T; Tsuji Y; Nakao K; Sakaguchi S; Tanaka M
    Arzneimittelforschung; 1988 Mar; 38(3):350-8. PubMed ID: 3382459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pinacidil on renal hemodynamics and function in anesthetized dogs.
    Morimoto S; Sasaki Y; Matsumura Y
    J Pharmacobiodyn; 1986 Feb; 9(2):146-55. PubMed ID: 3519923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic profile of the antihypertensive vasodilator cadralazine in conscious dogs.
    Dorigotti L; Ferni G; Lombroso M; Semeraro C
    Arzneimittelforschung; 1984; 34(9):984-7. PubMed ID: 6542375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute systemic and renal haemodynamic effects and long-term antihypertensive action of cadralazine in patients pretreated with beta-blockers and diuretics.
    Persson B; Granerus G; Wysocki M; Hedner T; Andersson OK
    Eur J Clin Pharmacol; 1987; 31(5):513-8. PubMed ID: 2881788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function studies with propildazine alone and in combination with propranolol in dogs.
    Dorigotti L; Semeraro C
    Eur J Pharmacol; 1980 Oct; 67(2-3):275-82. PubMed ID: 7461034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of combined vasodilation and beta-adrenoceptor blockade with prizidilol on renal function.
    Boehringer K; Weidmann P; Link L; Bianchetti MG; Schiffl H; Reubi FC
    Br J Clin Pharmacol; 1983 Feb; 15(2):181-8. PubMed ID: 6133543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 14 years of antihypertensive treatment on renal function and urinary albumin excretion in primary hypertension.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1996 Sep; 9(9):841-9. PubMed ID: 8879339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of felodipine on renal function in animals.
    DiBona GF
    Drugs; 1985; 29 Suppl 2():168-75. PubMed ID: 3987545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium entry blockers: antihypertensive and natriuretic effects in experimental animals.
    Nagao T; Yamaguchi I; Narita H; Nakajima H
    Am J Cardiol; 1985 Dec; 56(16):56H-61H. PubMed ID: 3878075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.
    Massingham R; Hayden ML
    Eur J Pharmacol; 1975 Jan; 30(1):121-4. PubMed ID: 1122933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of cadralazine on the respiration, circulation, kidney, autonomic nervous system, digestive system, blood and so on].
    Nishimori T; Nishimura T; Kobayashi F; Nakano D; Fukuda Y; Sakonjyo H; Nakanishi J; Kimura A; Tsuji H; Higashio T
    Nihon Yakurigaku Zasshi; 1988 Apr; 91(4):221-36. PubMed ID: 3391446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of the depressor, inotropic and renal effects of milrinone and CI-930 to different pure vasodilators and diuretics in conscious instrumented dogs.
    Lee KC; Clas DM; Gorczyca WP; Silver PJ; Ezrin AM
    Drugs Exp Clin Res; 1991; 17(7):323-36. PubMed ID: 1686584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mechanism of the acute antihypertensive and vasodilator actions of several beta-adrenoceptor antagonists.
    Sybertz EJ; Baum T; Pula KK; Nelson S; Eynon E; Sabin C
    J Cardiovasc Pharmacol; 1982; 4(5):749-58. PubMed ID: 6182405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine.
    Velasco M; Gilbert CA; Rutledge CO; McNay JL
    Clin Pharmacol Ther; 1975 Aug; 18(2):145-53. PubMed ID: 1097150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP; Opgenorth TJ; Salazar J; Romero JC; Burnett JC
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.